Nazzareno Galiè

88.5k total citations · 18 hit papers
409 papers, 27.7k citations indexed

About

Nazzareno Galiè is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Nazzareno Galiè has authored 409 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 299 papers in Pulmonary and Respiratory Medicine, 212 papers in Cardiology and Cardiovascular Medicine and 66 papers in Genetics. Recurrent topics in Nazzareno Galiè's work include Pulmonary Hypertension Research and Treatments (285 papers), Cardiovascular Issues in Pregnancy (87 papers) and Vascular Anomalies and Treatments (56 papers). Nazzareno Galiè is often cited by papers focused on Pulmonary Hypertension Research and Treatments (285 papers), Cardiovascular Issues in Pregnancy (87 papers) and Vascular Anomalies and Treatments (56 papers). Nazzareno Galiè collaborates with scholars based in Italy, United States and France. Nazzareno Galiè's co-authors include Lewis J. Rubin, Gérald Simonneau, Robyn J. Barst, Adaani Frost, Hossein Ardeschir Ghofrani, Anne Keogh, David B. Badesch, Marius M. Hoeper, Vallerie V. McLaughlin and Alessandra Manes and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Nazzareno Galiè

370 papers receiving 26.8k citations

Hit Papers

Bosentan Therapy for Pulmonary Arterial Hypertension 2001 2026 2009 2017 2002 2004 2002 2013 2013 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bosentan Therapy for Pulmonary Arterial Hypertension
    2002 2.0k citations Lewis J. Rubin, David B. Badesch et al. profile →
  2. Clinical classification of pulmonary hypertension
    2004 1.3k citations Gérald Simonneau, Nazzareno Galiè et al. profile →
  3. Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial
    2002 1.1k citations Gérald Simonneau, Robyn J. Barst et al. American Journal of Respiratory and Critical Care Medicine profile →
  4. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
    2013 948 citations Tomás Pulido, Richard N. Channick et al. profile →
  5. Riociguat for the Treatment of Pulmonary Arterial Hypertension
    2013 944 citations Hossein Ardeschir Ghofrani, Nazzareno Galiè et al. profile →
  6. Tadalafil Therapy for Pulmonary Arterial Hypertension
    2009 794 citations Nazzareno Galiè, Bruce H. Brundage et al. Circulation profile →
  7. Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
    2008 785 citations Nazzareno Galiè, Horst Olschewski et al. Circulation profile →
  8. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
    2015 750 citations Nazzareno Galiè, Adaani Frost et al. profile →
  9. Selexipag for the Treatment of Pulmonary Arterial Hypertension
    2015 706 citations Olivier Sitbon, Richard N. Channick et al. profile →
  10. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial
    2008 647 citations Nazzareno Galiè, Marius M. Hoeper et al. profile →
  11. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure
    2009 603 citations Nazzareno Galiè et al. profile →
  12. Bosentan Therapy in Patients With Eisenmenger Syndrome
    2006 578 citations Nazzareno Galiè, Maurice Beghetti et al. Circulation profile →
  13. Risk stratification and medical therapy of pulmonary arterial hypertension
    2018 521 citations Nazzareno Galiè, Richard N. Channick et al. European Respiratory Journal profile →
  14. Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia
    2001 518 citations Nazzareno Galiè, Nicholas W. Morrell et al. profile →
  15. Updated Treatment Algorithm of Pulmonary Arterial Hypertension
    2013 489 citations Nazzareno Galiè, Adaani Frost et al. profile →
  16. Pulmonary Hypertension Due to Left Heart Diseases
    2013 444 citations Nazzareno Galiè et al. profile →
  17. Pulmonary Hypertension in Chronic Lung Diseases
    2013 438 citations Nazzareno Galiè et al. profile →
  18. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
    2013 411 citations Marius M. Hoeper, Robyn J. Barst et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nazzareno Galiè Italy 76 24.2k 17.4k 4.7k 3.1k 2.6k 409 27.7k
Olivier Sitbon France 84 24.9k 1.0× 14.8k 0.8× 5.4k 1.1× 2.6k 0.8× 3.6k 1.4× 460 27.7k
David B. Badesch United States 62 23.3k 1.0× 15.2k 0.9× 4.5k 1.0× 2.3k 0.7× 3.0k 1.1× 180 25.9k
Vallerie V. McLaughlin United States 64 19.4k 0.8× 13.5k 0.8× 3.7k 0.8× 1.8k 0.6× 2.2k 0.8× 273 21.5k
Robyn J. Barst United States 82 30.6k 1.3× 21.2k 1.2× 6.6k 1.4× 4.6k 1.5× 3.5k 1.3× 250 34.2k
Michael D. McGoon United States 70 22.6k 0.9× 18.2k 1.0× 3.8k 0.8× 4.3k 1.4× 2.6k 1.0× 176 28.5k
Lewis J. Rubin United States 89 31.7k 1.3× 22.0k 1.3× 6.1k 1.3× 3.0k 1.0× 3.9k 1.5× 332 37.9k
Stuart Rich United States 68 19.2k 0.8× 14.3k 0.8× 3.7k 0.8× 2.2k 0.7× 2.3k 0.9× 183 23.1k
Adaani Frost United States 53 16.7k 0.7× 10.7k 0.6× 3.3k 0.7× 1.9k 0.6× 2.1k 0.8× 146 19.1k
David Montani France 67 13.8k 0.6× 6.7k 0.4× 2.6k 0.5× 1.3k 0.4× 1.3k 0.5× 397 16.6k
Richard N. Channick United States 51 13.0k 0.5× 9.1k 0.5× 2.9k 0.6× 1.3k 0.4× 1.4k 0.5× 222 14.7k

Countries citing papers authored by Nazzareno Galiè

Since Specialization
Citations

This map shows the geographic impact of Nazzareno Galiè's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nazzareno Galiè with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nazzareno Galiè more than expected).

Fields of papers citing papers by Nazzareno Galiè

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nazzareno Galiè. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nazzareno Galiè. The network helps show where Nazzareno Galiè may publish in the future.

Co-authorship network of co-authors of Nazzareno Galiè

This figure shows the co-authorship network connecting the top 25 collaborators of Nazzareno Galiè. A scholar is included among the top collaborators of Nazzareno Galiè based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nazzareno Galiè. Nazzareno Galiè is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiely, David G., Richard N. Channick, Dayana Flores, et al.. (2024). Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIR. ERJ Open Research. 10(1). 547–2023. 1 indexed citations
2.
Suma, Nicole, Sara Amicone, Angelo Sansonetti, et al.. (2023). Diagnostic agreement between echocardiography and second-level imaging techniques in patients with cardiac masses. European Heart Journal. 44(Supplement_2).
3.
Palazzini, Massimiliano, et al.. (2023). Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease. European Heart Journal Supplements. 25(Supplement_B). B90–B94.
4.
Russo, Antonio, L. Giovannini, Elena Sabattini, et al.. (2021). Donor‐derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report. Transplant Infectious Disease. 23(4). e13609–e13609. 9 indexed citations
5.
Saia, Francesco, Tullio Palmerini, Nevio Taglieri, et al.. (2020). Routine minimalist transcatheter aortic valve implantation with local anesthesia only. Journal of Cardiovascular Medicine. 21(10). 805–811. 7 indexed citations
6.
Galiè, Nazzareno, Olivier Sitbon, Martin Doelberg, et al.. (2020). Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study. European Heart Journal. 41(Supplement_2). 2 indexed citations
7.
Dardi, Fabio, Massimiliano Palazzini, Enrico Gotti, et al.. (2019). Abstract 9570: Prognostic Value of Stroke Volume Index in Patients With Pulmonary Arterial Hypertension at Intermediate Risk. Circulation. 1 indexed citations
8.
Gatzoulis, Michael Α., Michael J. Landzberg, Maurice Beghetti, et al.. (2018). Evaluation of Macitentan in Patients With Eisenmenger Syndrome. Circulation. 139(1). 51–63. 78 indexed citations
9.
Galiè, Nazzareno, Christopher P. Denton, Fabio Dardi, et al.. (2017). Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease. International Journal of Cardiology. 235. 67–72. 14 indexed citations
10.
Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138. 411 indexed citations breakdown →
11.
Sitbon, Olivier, Richard N. Channick, Marion Delcroix, et al.. (2013). Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH). European Respiratory Journal. 42(Suppl 57). P4060–P4060. 5 indexed citations
12.
Galiè, Nazzareno, Massimiliano Palazzini, & Alessandra Manes. (2012). Vasoactive Intestinal Peptide in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 185(7). 786–786. 6 indexed citations
13.
Jing, Zhi‐Cheng, Zaixin Yu, Jieyan Shen, et al.. (2011). Vardenafil in Pulmonary Arterial Hypertension: A Randomized, Double-blind, Placebo-controlled Study. American Journal of Respiratory and Critical Care Medicine. 183(12). 1723–1729. 138 indexed citations
14.
Galiè, Nazzareno, Robyn J. Barst, Bruce H. Brundage, et al.. (2011). Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease. European Respiratory Journal. 38(Suppl 55). p2299–p2299. 1 indexed citations
15.
Hoeper, Marius M., Robyn J. Barst, Nazzareno Galiè, et al.. (2011). Imatinib in pulmonary arterial hypertension, a randomized, efficacy study (IMPRES). European Respiratory Journal. 38(Suppl 55). 413–413. 11 indexed citations
16.
Galiè, Nazzareno, Horst Olschewski, Ronald J. Oudiz, et al.. (2008). Ambrisentan for the Treatment of Pulmonary Arterial Hypertension. Circulation. 117(23). 3010–3019. 785 indexed citations breakdown →
17.
Torbicki, Adam, Arnaud Perrier, Stavros Konstantinides, et al.. (2008). Guías de práctica clínica de la Sociedad Europea de Cardiología. Guías de práctica clínica sobre diagnóstico y manejo del tromboembolismo pulmonar agudo. Revista Española de Cardiología. 61(12). 1 indexed citations
18.
Gatzoulis, M., Maurice Beghetti, Nazzareno Galiè, et al.. (2006). Bosentan shows persistent benefit in functional class and exercise capacity amongst Eisenmenger patients in the BREATHE-5 open label extension study. European Heart Journal. 27. 8–9. 1 indexed citations
19.
Galiè, Nazzareno, Maurice Beghetti, Michael Α. Gatzoulis, et al.. (2006). Bosentan Therapy in Patients With Eisenmenger Syndrome. Circulation. 114(1). 48–54. 578 indexed citations breakdown →
20.
Simonneau, Gérald, Robyn J. Barst, Nazzareno Galiè, et al.. (2002). Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 165(6). 800–804. 1052 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Sitbon Breakdown of academic impact, for papers by David B. Badesch Breakdown of academic impact, for papers by Vallerie V. McLaughlin Breakdown of academic impact, for papers by Robyn J. Barst Breakdown of academic impact, for papers by Michael D. McGoon Breakdown of academic impact, for papers by Lewis J. Rubin Breakdown of academic impact, for papers by Stuart Rich Breakdown of academic impact, for papers by Adaani Frost Breakdown of academic impact, for papers by David Montani Breakdown of academic impact, for papers by Richard N. Channick
Rankless by CCL
2026